# Central California Blood Center – FDA Inspection, Oct 18, 2019

Source: https://www.keypedia.com/records/fda_inspections/central-california-blood-center/76455a6f-b6e7-4471-85ae-25e3a3edf158
Source feed: FDA_Inspections

> FDA inspection 1108061 of Central California Blood Center, October 18, 2019. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1108061
- Company Name: Central California Blood Center
- Inspection Date: 2019-10-18
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1319874 - 2026-04-24
- FDA Inspection 1049255 - 2018-03-02
- FDA Inspection 967701 - 2016-04-18
- FDA Inspection 856690 - 2013-11-25
- FDA Inspection 797705 - 2012-09-10

Company: https://www.keypedia.com/companies/central-california-blood-center/320acec4-bf09-4418-98b2-c4b28e275f2e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d